Piramal Pharma share price target

• investments

Indian CRDMO Industry is entering a multi-year growth cycle. Best 5 stocks to buy for up to 55% upside by JMFICS

Arjun November 8, 2025

The listed Indian CRDMO players have entered a sustained growth phase (17% revenue CAGR...

Read More

• investments

Piramal Pharma has one more blockbuster win in CDMO. Buy for target price of ₹313 (67.6% upside): JMFICS

Arjun September 3, 2025

Piramal Pharma Solutions (PPS), the CDMO arm of Piramal Pharma, has announced a multi...

Read More

• investments

Piramal Pharma has an ambitious roadmap to nearly double revenues in key segments by FY30. Buy for target price of ₹295 (53% upside): JMFICS

Arjun August 21, 2025

We recently hosted Piramal Pharma Ltd at the JM Financial Promoter Conference, represented...

Read More

• investments

Piramal Pharma’s long term prospects are intact. Buy for target price of ₹290 (38% upside): ICICI Direct

Arjun May 15, 2025

Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company...

Read More